Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases

A technology of triterpene saponins and autoimmunity, which is applied in bone diseases, drug combinations, allergic diseases, etc., and can solve the problems of non-specific immunosuppression of the body, large side effects, and no specific treatment methods.

Inactive Publication Date: 2013-03-06
WUHAN DAO YI TANG PHARMA RES INST
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In terms of curative effect, these drugs are only 70-80% effective
[0009] 2) Glucocorticoid drugs - anti-inflammatory, suppress immune inflammation, the application of glucocorticoids in the treatment of rheumatism can only alleviate the condition, easy to relapse after stopping the drug, and long-term use has serious side effects, so comprehensive treatment must be used, generally not as the first choice drug
Because its pathogenesis is not completely clear, there is no specific treatment at present (Lu Junjian, Chinese and Western Medicine Diagnosis and Treatment of Connective Tissue Diseases, People's Health Publishing House, 1992: 348)
Comprehensive treatment such as corticosteroid hormones and cytotoxic drugs is often used clinically, but this often leads to adverse consequences such as non-specific immunosuppression of the body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases
  • Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases
  • Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0051] The synthetic method of the triterpene saponin compound shown in the above general chemical formula I specifically comprises the following steps:

[0052] Step 1: protecting the hydroxyl group of the five- or six-membered sugar or its derivative; reacting trichloroacetonitrile or mercaptan with the hemiacetal hydroxyl group of the hydroxyl-protected sugar or its derivative to obtain at least one compound A standby;

[0053] Step 2: reacting triphenylchloromethane with oleanolic acid or ursolic acid to obtain compound B for later use;

[0054] Step 3: reacting at least one compound A with compound B and deprotecting with sodium alkoxide to give R 5 A compound of general chemical formula I which is a hydrogen atom; or

[0055] reacting at least one compound A with compound B, and deprotecting with acetic acid, then reacting with at least one compound A prepared in step 1, and then deprotecting with sodium methoxide, wherein the at least one compound A can be same or ...

Embodiment 1

[0079] Example 1 Synthesis of oleanolic acid 3-O-α-L-rhamnopyranose

[0080] The natural products α-L-rhamnopyranose (compound 1, purchased from Kebosi Biotechnology Co., Ltd.) and oleanolic acid (compound 5, purchased from Xi'an Guanyu Biotechnology Co., Ltd.) were used as starting materials. The synthesis is carried out according to the reaction scheme shown below.

[0081]

[0082]

[0083] Specifically, 20 g of compound 1 (α-L-rhamnopyranose) was stirred under an ice bath, 75 ml of benzoyl chloride (BzCl) was dissolved in 150 ml of pyridine (Pyr) as solvent I, and slowly dropped into the above solution , stirred overnight at room temperature, and after the completion of the reaction was detected by thin-layer chromatography, it was concentrated under reduced pressure and purified and separated by column chromatography (petroleum ether / ethyl acetate=5 / 1) to obtain compound 2 (33.8 g). Compound 2 was dissolved in a mixed solvent of tetrahydrofuran (THF) and methanol (...

Embodiment 2

[0091] Example 2 Synthesis of oleanolic acid 3-O-α-L-rhamnopyranose 28-O-α-L-rhamnopyranoside

[0092] Compound 7 and Compound 4 obtained in Example 1 were used as starting materials. The synthesis is carried out according to the reaction scheme shown below.

[0093]

[0094] Compound 8 (8 g) obtained in Example 1 was added with 20 ml of 80% acetic acid, and stirred at 70° C. for 2 hours. After the reaction was complete after detection by thin layer chromatography, it was concentrated under reduced pressure and analyzed by column chromatography (petroleum ether / ethyl acetate). Ester=7 / 1) was purified and separated to obtain compound 9 (6.4 g).

[0095] Under nitrogen protection, compound 9 (4g) and compound 4 (2.3g) were dissolved in 100ml of dichloromethane as solvent II, 1.1g of N-iodosuccinimide was added with stirring at room temperature, and the temperature was lowered to -40°C~ -50°C, add 100 μl of trimethylsilyl trifluoromethanesulfonate, stir at -35°C to -45°C for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of a triterpenoid saponin compound in the preparation of medicaments for treating autoimmune diseases, in particular to application of a triterpenoid saponin compound in the preparation of medicaments for treating transplanting rejection, bronchial asthma, hepatitis B virus (HBV), nephrotic syndrome, yin-deficiency in hyperthyreosis or systemic lupus erythematosus. The triterpenoid saponin compound is shown by a chemical general formula as below, wherein in the chemical general formula, any two of R1, R2 and R3 are methyl, and the left one is a hydrogen atom; R4 is pentahydric or hexahydric monosaccharide, or disaccharide formed by the pentahydric or hexahydric monosaccharide, or glycosyl formed by aldehyde acid derivatives of the monosaccharide or the disaccharide; and R5 is the hydrogen atom or the pentahydric or hexahydric monosaccharide or the disaccharide formed by the pentahydric or hexahydric monosaccharide or a substituent group formed by the aldehyde acid derivatives of the monosaccharide or the disaccharide. According to the application, the medicaments for treating the autoimmune diseases obviously are provided.

Description

technical field [0001] The present invention relates to the application of triterpene saponin compounds in the preparation of medicines for treating autoimmune diseases, in particular to the application of triterpene saponins in the preparation of medicines for treatment of transplant rejection, bronchial asthma, HBV, nephrotic syndrome, hyperthyroidism and yin deficiency, and systemic lupus erythematosus application. Background technique [0002] Traditional Chinese medicine is the material basis and carrier of TCM disease prevention and health care, which contains rich scientific connotations and extremely high practical value. With the continuous development of human health care and the trend of traditional Chinese medicine going global, the social demand for traditional Chinese medicine resources has increased unprecedentedly, and the contradiction between supply and demand has become increasingly prominent. The rational development and protection of traditional Chinese...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/704A61P37/02A61P37/06A61P11/06A61P31/20A61P1/16A61P13/12A61P5/16A61P19/04A61P25/28A61P35/00
Inventor 廖一帆江哲遒刘军李婧邴飞虹
Owner WUHAN DAO YI TANG PHARMA RES INST